Drug Discovery 2021 After the Storm: Re-connect, Re-invent, Re-imagine

19 October

Wed 20 October

[Schedule with Sessions only]

DAY 1

Room 3A

Room 3B

Hall 1B

Hall 1C

Room 11B - Workshop

Room 11C - Workshop

DAY 2

8:00

Event Registration

8:00:

8:05:

8:10:

8:15:

8:20:

8:25:

8:30:

8:35:

8:40:

8:45:

8:50:

Conference Welcome and Plenary Keynote Introduction

8:50:

8:55:

9:00

Plenary Keynote Presentation

Looking ahead: what is next for AI in drug discovery?
09:00 (50 mins)
Guido Lanza, Valo Health

9:00:

9:05:

9:10:

9:15:

9:20:

9:25:

9:30:

9:35:

9:40:

9:45:

9:50:

Early Career Professional Impact Award - Sponsored by SelectScience

Mind the gap… making a career out of building bridges
09:50 (20 mins)
Laura Ajram, Medicines Discovery Catapult

9:50:

9:55:

10:00

10:05

10:10

Refreshment Break

10:10

10:15

10:20

10:25

10:30

10:35

10:40

10:45

10:50

Screening Innovation to Enhance Drug Discovery - sponsored by Domainex

Chairs: Ian Storer, AstraZeneca Jeff Jerman, Lifearc

Innovative Strategies Supporting Drug Discovery

Chairs: Kenny Simmen, Johnson & Johnson Innovation Laura Dickens, UKRI - Medical Research Council

Disruptive technologies

Chairs: Carolina Wählby, Uppsala University Mark Roberts, Tessella

The British Pharmacological Society - Opportunities and Challenges of Drugging the Undruggable

Chairs: Nura Mohamed, Imperial College London

Workshop

“The Single-Cell Sequencing Revolution”
10:50 (80 mins)
Tilmann Buerckstuemmer — Aelian Biotechnology

Workshop

The challenges of cell models: Novel approaches and tools for basic research and drug discovery
10:50 (60 mins)
Zoe Nilsson — bit.bio

10:50

10:55

11:00

Screening Innovation to Enhance Drug Discovery - sponsored by Domainex

High-throughput proteomics for gene function prediction, target discovery and precision medicine
11:00 (30 mins)
Markus Ralser, Crick Institute / Dept Biochemistry, Berlin

Automated High-Speed and High-Throughput Screening with the ZE5 Cell Analyzer.
11:30 (30 mins)
Richard Cuthbert — Bio-Rad

Innovative Strategies Supporting Drug Discovery

The MRC’s COVID-19 Research Response
11:00 (30 mins)
Jonathan Pearce, UKRI- Medical Research Council

Innovation Strategies Supporting Drug Discovery
11:30 (30 mins)
Andrew Scott — Malvern Panalytical

Disruptive technologies

High resolution anatomical mapping of gene expression using targeted in situ sequencing
11:00 (30 mins)
Mats Nilsson, SciLifeLab

Development of an Image-Based HCS-Compatible Method for Endothelial Barrier Function Assessment
11:30 (30 mins)
Sun Yung — Nexcelom from PerkinElmer

The British Pharmacological Society - Opportunities and Challenges of Drugging the Undruggable

Sir James Black Award Presentation - Anti-CD20, new precision medicines from old targets
11:00 (30 mins)
Daren Austin, GlaxoSmithKline

Ficoll-free primary cell isolation for drug discovery assays
11:30 (30 mins)
Lotta Räty — Miltenyi Biotec

11:00

11:05

11:10

11:15

11:20

11:25

11:30

11:35

11:40

11:45

11:50

11:55

12:00

Screening Innovation to Enhance Drug Discovery - sponsored by Domainex

Automating Image Analysis with Deep Learning to Accelerate Drug Discovery and Increase Mechanistic Insight
12:00 (30 mins)
James Robinson, AstraZeneca

CETSA® Navigate HT: A new paradigm for high-throughput screening
12:30 (15 mins)
Fredrik Rahm — Pelago Bioscience AB

Accelerating the Next Generation of Immune Medicine with Fully Automated High-Plex Cellular Proteomics
12:45 (5 mins)
Mourad Ferhat — ISOPLEXIS

#GEEKE SPEAK: If u * do wat y’ve * done, y’ll * get wat ye * got (*=?)
12:50 (5 mins)
Gary Allenby — Aurelia Bioscience

Quantification of molecular interactions by a novel ligand-induced spectral shift technology
12:55 (5 mins)
Ravindra Chaudhari — NanoTemper Technologies

Innovative Strategies Supporting Drug Discovery

Improving diversity in health research and clinical trials
12:00 (30 mins)
Annette Crosse, Egality

De-risking drug development by early translational pharmacology
12:30 (15 mins)
Charlotte Kopitz — NUVISAN

Connected Lab Automation for Dynamic Data Exchange
12:45 (5 mins)
Matt Taylor — Thermo Fisher Scientific

Traceability, accountability, and data integrity: GxP software for image acquisition and analysis
12:50 (5 mins)
Mark Graham — Cytiva

Data Management for Collaborative Drug Discovery
12:55 (5 mins)
Tamsin Lamont — Collaborative Drug Discovery

Disruptive technologies

Live cell compatible super resolution fluorescence microscopy for 3D imaging
12:00 (30 mins)
Ilaria Testa, SciLifeLab Francesca Pennacchietti

Single-cell CRISPR screens in primary human T cells
12:30 (15 mins)
Tilmann Buerckstuemmer — Aelian Biotechnology

R&D at the New Speed of Science: Accelerate your R&D Transformation with Benchling
12:45 (5 mins)
Tali Bloom — Benchling

Introducing an electronic sensor to measure affinity of intermolecular interactions
12:50 (5 mins)
Sylwia Mankowska — HexagonFab

All Human Drug Research Solutions
12:55 (5 mins)
Paul Gallant — LifeNet Health LifeSciences

The British Pharmacological Society - Opportunities and Challenges of Drugging the Undruggable

Tracking GPCR signalling- from the outside in one cell at a time
12:00 (30 mins)
Terence Hébert, McGill University

Enabling drug discovery with diverse lead generation platforms
12:30 (15 mins)
David Madge — WuXi AppTec

Get More Out of BioMAP® Early Screening Data with Tableau
12:45 (5 mins)
Ellen Berg — Eurofins Discovery

Bioluminescent Tools & Approaches for RAS Pathway Drug Discovery
12:50 (5 mins)
Craig Malcolm — Promega UK Ltd

How Organ-on-a-Chip is being used across drug discovery - from target validation to regulatory acceptance
12:55 (5 mins)
Tomasz Kostrzewski — CN Bio

12:00

12:05

12:10

12:15

12:20

12:25

12:30

12:35

12:40

12:45

12:50

12:55

1:00

Refreshment Break

Workshop

Chairs: Lilian Hunt, EDIS, Wellcome Trust

Equality, Diversity and Inclusion: Awareness to action
13:00 (60 mins)
Lilian Hunt, EDIS, Wellcome Trust

1:00:

1:05:

1:10:

1:15:

1:20:

1:25:

1:30:

1:35:

1:40:

1:45:

1:50:

1:55:

2:00

2:00:

2:05:

2:10:

2:15:

2:20:

2:25:

2:30:

Screening Innovation to Enhance Drug Discovery - sponsored by Domainex

Generation of fully human antibodies using high throughput IntelliSelect® Technology Platforms at LifeArc
14:30 (30 mins)
Preeti Bakrania, LifeArc

Alignment of Chemogenomic and Functional Genomic screening for target ID
15:00 (30 mins)
Joanna Redmond, GlaxoSmithKline

Innovative Strategies Supporting Drug Discovery

Democratising Drug Discovery – Widening Access to Expertise and Technologies
14:30 (30 mins)
Peter Simpson, Medicines Discovery Catapult

Open drug discovery on the edge - the COVID Mooonshot's quest for an antiviral pill
15:00 (30 mins)
Frank von Delft, Diamond

Disruptive technologies

Chemical Materials Design
14:30 (30 mins)
Ben Slater, Materials Innovation Factory (MIF)

Quantum computing: a new frontier in drug discovery?
15:00 (30 mins)
Sam Genway, Capgemini Engineering

The British Pharmacological Society - Opportunities and Challenges of Drugging the Undruggable

Effects of small molecule compounds targeting osteoclasts against RA bone destruction
14:30 (30 mins)
Yanhui Tan, Guangxi Normal University, Guilin, China

Bio-inspired nanoformulations for delivery of advanced therapeutics
15:00 (30 mins)
Rongjun Chen, Imperial College London

Workshop

Learn to Learn
14:30 (90 mins)
Chris Williams, Questae Coaching & Consulting Ltd

2:30:

2:35:

2:40:

2:45:

2:50:

2:55:

3:00

3:00:

3:05:

3:10:

3:15:

3:20:

3:25:

3:30:

Comfort Break

3:30:

3:35:

3:40:

Screening Innovation to Enhance Drug Discovery - sponsored by Domainex

A Huntington’s disease embryonic stem cell phenotypic HTS to identify small molecule modulators of mutant HTT
15:40 (30 mins)
Marta Stebbeds, Discovery from Charles River

High-throughput PROTAC synthesis for direct, biological assaying
16:10 (30 mins)
David Battersby, GlaxoSmithKline

Innovative Strategies Supporting Drug Discovery

'Virtual Reality’ – Adding a New Dimension to Drug Design
15:40 (30 mins)
Timur Avkiran

Transforming Research and Medicine through Synthetic Biology
16:10 (30 mins)
Helen Horton, Touchlight

Disruptive technologies

A structural biology community assessment of AlphaFold 2 applications
15:40 (30 mins)
Pedro Beltrao, EMBL-EBI

MELLODDY: privacy-preserving federated machine learning across pharma partners
16:10 (30 mins)
Hugo Ceulemans, Janssen Pharmaceutica

3:40:

3:45:

3:50:

3:55:

4:00

4:00:

4:05:

4:10:

4:15:

4:20:

4:25:

4:30:

4:35:

4:40:

Conference Close and Awards

4:40:

4:45:

4:50:

4:55:

5:00

5:00:

5:05:

5:10:

5:15:

5:20:

5:25:

5:30:

5:35:

5:40:

5:45:

5:50:

5:55:

6:00

6:00:

6:05:

6:10:

6:15:

6:20:

6:25:

6:30:

6:35:

6:40:

6:45:

6:50:

6:55:

7:00

7:00: